Tag Archives: patents

ISC Patent On Making Human Stem Cells Advances Cloning Technology

  sale viagra without prescription Apart from being praised as an ethical work-around to the problems of destroying early-stage human embryos—often about to be discarded as surplusage by fertility clinics — to obtain human pluripotent stem cells, Revazova et al. … Continue reading

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , | Leave a comment

DNA As Information. “Synthetic Genome” Paper Brings New Life To Old Debate

In the landmark paper by Gibson, Smith, Venter et al, Science Express (May 20, 2010), reporting the successful replacement of one bacterial genome by a completely synthetic, functional chromosome,  the authors note: “This work provides a proof of principle for … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | Leave a comment

A “Myriad” Of Questions To Resolve? Back To The Basics Of 101

Thinking about Judge Sweet’s recent decision in Ass’n of Molecular Pathologists v. USPTO et al. (The “Myriad Decision”), I am again struck by the wide path the good judge slashed through the field (or is it the jungle now) of … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , | Leave a comment

Director Kappos Comments on Ariad v. Lilly

USPTO David Kappos recently posted a comment on the Fed. Cir. decision in Ariad v. Lilly in which he noted that the Fed. Cir. held that broad functional claims (presumably mechanism-of-action claims) must be supported by sufficient species (read “working examples”). While … Continue reading

Posted in Written Description Requirements (WDR) | Tagged , , , , , | Leave a comment